Property, Plant and Equipment, Gross of Vistagen Therapeutics, Inc. from 31 Mar 2012 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
Summary
Vistagen Therapeutics, Inc. quarterly Property, Plant and Equipment, Gross in USD history and change rate from 31 Mar 2012 to 31 Mar 2025.
  • Vistagen Therapeutics, Inc. Property, Plant and Equipment, Gross for the quarter ending 31 Mar 2025 was $1,880,000, a 11% increase year-over-year.
Source SEC data
View on sec.gov
Property, Plant and Equipment, Gross, Quarterly (USD)
Property, Plant and Equipment, Gross, YoY Quarterly Change (%)

Vistagen Therapeutics, Inc. Quarterly Property, Plant and Equipment, Gross (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $1,880,000 +$191,000 +11% 31 Mar 2025 10-K 17 Jun 2025 2025 FY
Q1 2024 $1,689,000 -$11,000 -0.65% 31 Mar 2024 10-K 17 Jun 2025 2025 FY
Q2 2023 $1,700,700 -$153,400 -8.3% 30 Jun 2023 10-Q 10 Aug 2023 2024 Q1
Q1 2023 $1,700,000 +$16,900 +1% 31 Mar 2023 10-K 11 Jun 2024 2024 FY
Q4 2022 $1,891,000 +$207,900 +12% 31 Dec 2022 10-Q 07 Feb 2023 2022 Q3
Q3 2022 $1,878,500 +$156,600 +9.1% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q2
Q2 2022 $1,854,100 +$182,700 +11% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q1
Q1 2022 $1,683,100 +$161,600 +11% 31 Mar 2022 10-K 28 Jun 2023 2023 FY
Q4 2021 $1,683,100 +$187,100 +13% 31 Dec 2021 10-Q 10 Feb 2022 2022 Q3
Q3 2021 $1,721,900 +$376,900 +28% 30 Sep 2021 10-Q 10 Nov 2021 2022 Q2
Q2 2021 $1,671,400 +$425,300 +34% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q1
Q1 2021 $1,521,500 +$275,400 +22% 31 Mar 2021 10-K 23 Jun 2022 2022 FY
Q4 2020 $1,496,000 +$249,900 +20% 31 Dec 2020 10-Q 11 Feb 2021 2021 Q3
Q3 2020 $1,345,000 +$98,900 +7.9% 30 Sep 2020 10-Q 12 Nov 2020 2021 Q2
Q2 2020 $1,246,100 $0 0% 30 Jun 2020 10-Q 13 Aug 2020 2021 Q1
Q1 2020 $1,246,100 $0 0% 31 Mar 2020 10-K 29 Jun 2021 2021 FY
Q4 2019 $1,246,100 +$4,300 +0.35% 31 Dec 2019 10-Q 13 Feb 2020 2020 Q3
Q3 2019 $1,246,100 +$4,300 +0.35% 30 Sep 2019 10-Q 07 Nov 2019 2020 Q2
Q2 2019 $1,246,100 +$30,000 +2.5% 30 Jun 2019 10-Q 13 Aug 2019 2020 Q1
Q1 2019 $1,246,100 +$196,600 +19% 31 Mar 2019 10-K 29 Jun 2020 2020 FY
Q4 2018 $1,241,800 31 Dec 2018 10-Q 12 Feb 2019 2019 Q3
Q3 2018 $1,241,800 30 Sep 2018 10-Q 29 Oct 2018 2019 Q2
Q2 2018 $1,216,100 30 Jun 2018 10-Q 14 Aug 2018 2019 Q1
Q1 2018 $1,049,500 +$1,600 +0.15% 31 Mar 2018 10-K 25 Jun 2019 2019 FY
Q1 2017 $1,047,900 +$249,300 +31% 31 Mar 2017 10-K 26 Jun 2018 2018 FY
Q1 2016 $798,600 +$16,400 +2.1% 31 Mar 2016 10-K 29 Jun 2017 2017 FY
Q1 2015 $782,200 $0 0% 31 Mar 2015 10-K 24 Jun 2016 2016 FY
Q1 2014 $782,200 +$50,200 +6.9% 31 Mar 2014 10-K 29 Jun 2015 2015 FY
Q1 2013 $732,000 +$127,700 +21% 31 Mar 2013 10-K 25 Jun 2014 2014 FY
Q1 2012 $604,300 31 Mar 2012 10-K 18 Jul 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.